Search
Abbott Laboratories
ABTAdd to Watchlist
113.600USD
-1.910-1.65%
Close 11-05 16:00（ET）
196.57BMarket Cap
31.51P/E TTM
After-hours 19:45 (ET)113.570USD+0.070+0.06%
After-hours 19:45 (ET)Abbott Laboratories (ABT) Stock Price Target & Forecast
Analyst Rating
Based on 28 analysts giving stock ratings to Abbott Laboratories in the past month.
Buy
11 Strong Buy
13 Buy
4 Hold
0 Sell
0 Strong Sell
Target Price
119.491USD+12.52%
ABT Analyst Recommendation Trends
In the current month, ABT has received 13 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. ABT average Analyst price target in the last month is 119.491.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
11
11
10
10
9
9
9
9
13
12
11
12
12
13
14
13
4
5
8
9
9
9
8
9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
28
28
29
31
30
31
31
31
ABT Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Stryker Corp
SYK
10
14
6
0
0
30
Medtronic PLC
MDT
8
11
10
0
0
29
Dexcom Inc
DXCM
13
12
4
0
0
29
Guardant Health Inc
GH
12
14
2
0
0
28
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Zimmer Biomet Holdings Inc
ZBH
2
5
20
0
0
27
Insulet Corp
PODD
7
7
12
0
0
26
Tandem Diabetes Care Inc
TNDM
5
8
10
0
0
23
Repligen Corp
RGEN
5
12
4
0
0
21
Alcon AG
ALC
6
9
3
1
0
19
Financial Forecasting
Based on analysts' estimates, ABT EPS is projected to reach 1.638 in FY2026Q4, following reported EPS of 0.530 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
1.14
1.28
1.42
1.64
1.23
Actual
0.62
0.53
0.53
--
--
Surprise
-45.96%
-58.32%
-62.53%
--
--
FAQs
What is Abbott Laboratories's expected revenue for the next quarter?
Abbott Laboratories's expected revenue is 13.25B.
What is Abbott Laboratories's price target?
Analysts forecast that Abbott Laboratories's price target is USD 119.49, with the highest forecast at USD 136.00 and the lowest forecast at USD 103.00.
How have Abbott LaboratoriesABT's recent earnings per share performed?
The market expectation was USD 0.53, while Abbott LaboratoriesABT's earnings per share (EPS) for the previous quarter was USD 0.53. EPS for the next quarter is expected at USD 1.64.
What is the analyst rating for Abbott Laboratories?
Based on the ratings of Abbott Laboratories's stock from 28 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.